Park T H, McHowat J, Wolf R A, Corr P B
Cardiovascular Division, Washington University School of Medicine, St Louis, Missouri 63110.
Cardiovasc Res. 1994 Aug;28(8):1263-8. doi: 10.1093/cvr/28.8.1263.
The aims were (1) to determine whether thrombin, which is increased in the presence of coronary thrombosis, can directly stimulate the production of lysophosphatidylcholine, which has arrhythmogenic properties, in ventricular myocytes; (2) whether the effect is dependent upon extracellular [Ca2+]; and (3) whether it is mediated directly through stimulation of the thrombin receptor.
Lipids were extracted from isolated adult rabbit ventricular myocytes and lysophosphatidylcholine was isolated by HPLC and quantified using a recently developed radiometric assay employing 3H-acetic anhydride.
Thrombin (0.05 U.ml-1) stimulation of ventricular myocytes resulted in a nearly sixfold increase in lysophosphatidylcholine levels [0.26(SEM 0.03) to 1.61(0.42) nmol.mg-1 protein] within 1 min. The increase in myocytic lysophosphatidylcholine content was prevented by preincubation of thrombin with the proteolytic site inhibitors phenyly-prolyl-arginyl-chloromethyl ketone (PPACK) and dansylarginine N-(3-ethyl-1,5-pentanediyl)amide. The increase in lysophosphatidylcholine content in response to thrombin was not present at an extracellular calcium concentration ([Ca2+)]o) = 500 microM, but was marked at a physiological level of [Ca2+]o = 1.8 mM. Stimulation of myocytes with the thrombin receptor activating peptide SFLLRNPNDKYEPF (100 microM for 1 min) resulted in a similar increase in lysophosphatidylcholine content [1.61(0.27) nmol.mg-1 protein].
The marked increase in lysophosphatidylcholine content in cardiac myocytes in response to thrombin has important implications as an arrhythmogenic mechanism during early myocardial ischaemia.
本研究旨在(1)确定在冠状动脉血栓形成时增加的凝血酶是否能直接刺激具有致心律失常特性的溶血磷脂酰胆碱在心室肌细胞中的产生;(2)该效应是否依赖于细胞外[Ca2+];以及(3)其是否通过刺激凝血酶受体直接介导。
从成年兔分离的心室肌细胞中提取脂质,通过高效液相色谱法分离溶血磷脂酰胆碱,并使用最近开发的采用3H-乙酸酐的放射性测定法进行定量。
凝血酶(0.05 U.ml-1)刺激心室肌细胞导致1分钟内溶血磷脂酰胆碱水平几乎增加了6倍[从0.26(标准误0.03)增加到1.61(0.42) nmol.mg-1蛋白质]。用蛋白水解位点抑制剂苯甲酰-脯氨酰-精氨酰-氯甲基酮(PPACK)和丹磺酰精氨酸N-(3-乙基-1,5-戊二酰)酰胺预孵育凝血酶可阻止肌细胞溶血磷脂酰胆碱含量的增加。在细胞外钙浓度([Ca2+]o)=500 microM时,对凝血酶反应的溶血磷脂酰胆碱含量增加不存在,但在生理水平的[Ca2+]o=1.8 mM时显著。用凝血酶受体激活肽SFLLRNPNDKYEPF(100 microM,1分钟)刺激肌细胞导致溶血磷脂酰胆碱含量类似的增加[1.61(0.27) nmol.mg-1蛋白质]。
心肌细胞中溶血磷脂酰胆碱含量对凝血酶的显著增加作为早期心肌缺血期间的致心律失常机制具有重要意义。